Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication.

Fifty-one men with atherosclerotic intermittent claudication and haemorheological abnormalities completed a double-blind, one-year randomised trial of Ticlopidine (500 mg/day), a new antiplatelet agent. Ticlopidine caused significant inhibition of platelet aggregation but did not fully correct abnor...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Clin Pathol
Autors principals:	Aukland, A, Hurlow, R A, George, A J, Stuart, J
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 1982
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC497768/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7047575/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.35.7.740
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!